Cytotoxicity of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine and its relationship to deoxycytidine deaminase.
D000970:Antineoplastic Agents / Q000378:metabolism*; D003561:Cytarabine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D003844:DCMP Deaminase / Q000378:metabolism*; D003842:Deoxycytidine Kinase / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000201:enzymology; D009709:Nucleotide Deaminases / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013937:Thymidine Kinase / Q000378:metabolism
D000970:Antineoplastic Agents; D003561:Cytarabine; C026023:fiacitabine; D013937:Thymidine Kinase; D003842:Deoxycytidine Kinase; D009709:Nucleotide Deaminases; D003844:DCMP Deaminase